help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 22, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0077
A more recent version of this article appeared on July 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/7/2786    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kowalska, I.
Right arrow Articles by Górska, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kowalska, I.
Right arrow Articles by Górska, M.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology
Right arrow Metabolism
Right arrow Obesity

Submitted on January 11, 2008
Accepted on April 16, 2008

Serum retinol binding protein 4 is related to insulin resistance and non-oxidative glucose metabolism in lean and obese women with normal glucose tolerance

Irina Kowalska*, Marek Straczkowski, Agnieszka Adamska, Agnieszka Nikolajuk, Monika Karczewska-Kupczewska, Elzbieta Otziomek, and Maria Górska

Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Poland

* To whom correspondence should be addressed. E-mail: irinak{at}poczta.onet.pl.

Context: Retinol-binding protein (RBP) 4 is secreted by adipose tissue and is postulated to be a determinant of insulin sensitivity. The mechanisms of RBP4 insulin desensitizing action remain unclear.

Objective: The aim of the present study was to estimate the relationships between serum RBP4 concentration with insulin sensitivity and oxidative and non-oxidative glucose metabolism in lean and obese women.

Design and participants: The study group consisted of 67 women with normal glucose tolerance, 27 lean and 40 overweight or obese. Insulin sensitivity was estimated with the euglycemic hyperinsulinemic clamp. Glucose and lipid oxidation was measured with indirect calorimetry in the basal state and during the last 30 minutes of the clamp. Non-oxidative glucose metabolism was calculated in insulin-stimulated conditions by subtracting glucose oxidation from total glucose metabolism.

Results: There was no difference in serum RBP4 concentration between lean and obese women. Serum RBP4 was inversely related to insulin sensitivity and non-oxidative glucose metabolism in the entire group (r=-0.36, p=0.003 in both cases) and within the subgroups of lean (r=-0.41, p=0.034 and r=-0.41, p=0.031) and obese women (r=-0.41, p=0.009 and r=-0.40, p=0.01, respectively). These relationships were independent of potential confounding factors. RBP4 levels were not associated with oxidative metabolism of glucose or lipid.

Conclusions: Our data indicate that serum RBP4 is related to decreased insulin sensitivity mostly through its association with non-oxidative glucose metabolism.


Key words: retinol-binding protein 4 • insulin resistance • non-oxidative glucose metabolism







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society